Form 4 for GH Guardant Health, Inc.
Accepted 2021-09-14 00:00:00 ET · period of report 2021-09-10 · accession 0001576280-21-000090 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-14 | 2021-09-10 | GH | MERESMAN STANLEY J | Dir | S - Sale+OE | $129.78 | -4,934 | 4,859 | -50% | -$640.3K |
| D | 2021-09-14 | 2021-09-10 | GH | MERESMAN STANLEY J | Dir | M - OptEx | $5.94 | +4,934 | 8,993 | +122% | +$29.3K |
| D | 2021-09-14 | 2021-09-10 | GH | MERESMAN STANLEY J | Dir | M - OptEx | $0.00 | -4,934 | 39.5K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2021-09-10 | S | D | 3,052 | $129.31 | 5,941 | D | — | — | (F1) These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $128.85 to $129.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 2 | Common | COMMON STOCK | 2021-09-10 | S | D | 800 | $131.12 | 4,059 | D | — | — | (F1) These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. |
| 3 | Common | COMMON STOCK | 2021-09-10 | S | D | 1,082 | $130.11 | 4,859 | D | — | — | (F1) These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $129.86 to $130.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 4 | Common | COMMON STOCK | 2021-09-10 | M | A | 4,934 | $5.94 | 8,993 | D | — | — | |
| 5 | Derivative | STOCK OPTION (RIGHT TO BUY) | 2021-09-10 | M | D | 4,934 | $0.00 | 39,473 | D | $5.94 · — to 2028-05-09 | 4,934 COMMON STOCK | (F4) The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. |